Header Logo

Connection

TITO R MENDOZA to Neoplasms

Back to Details
This is a "connection" page, showing publications TITO R MENDOZA has written about Neoplasms.
TITO R MENDOZA
Connection Strength
1.771
Neoplasms
  1. Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial. Sci Rep. 2022 08 23; 12(1):14367.
    View in: PubMed
    Score: 0.138
  2. Development and Validation of a Patient-reported Outcome Measure for Gastrointestinal Obstruction in the Setting of Advanced Malignancy. Ann Surg. 2022 Dec 01; 276(6):e805-e811.
    View in: PubMed
    Score: 0.124
  3. New Developments in the Use of Patient-Reported Outcomes in Cancer Patients Undergoing Immunotherapies. Adv Exp Med Biol. 2020; 1244:335-339.
    View in: PubMed
    Score: 0.115
  4. Symptoms as Patient-Reported Outcomes in Cancer Patients Undergoing Immunotherapies. Adv Exp Med Biol. 2018; 995:165-182.
    View in: PubMed
    Score: 0.100
  5. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE. Clin Trials. 2017 Jun; 14(3):255-263.
    View in: PubMed
    Score: 0.095
  6. Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventory. Oncology. 2010; 79(1-2):112-7.
    View in: PubMed
    Score: 0.061
  7. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients. Oncology. 2004; 67(3-4):203-10.
    View in: PubMed
    Score: 0.038
  8. Should We Use COMM (Current Opioid Misuse Measure) to Screen for Opioid Abuse in Patients With Cancer Pain? J Natl Compr Canc Netw. 2023 11; 21(11):1132-1140.e3.
    View in: PubMed
    Score: 0.038
  9. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes. 2023 05 26; 7(1):48.
    View in: PubMed
    Score: 0.036
  10. Assessing gaps in motherhood after cancer: development and psychometric testing of the Survivorship Oncofertility Barriers Scale. Int J Gynecol Cancer. 2023 05 01; 33(5):778-785.
    View in: PubMed
    Score: 0.036
  11. Impact of an Interdisciplinary Goals-of-Care Program Among Medical Inpatients at a Comprehensive Cancer Center During the COVID-19 Pandemic: A Propensity Score Analysis. J Clin Oncol. 2023 01 20; 41(3):579-589.
    View in: PubMed
    Score: 0.035
  12. Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques. PLoS One. 2022; 17(8):e0272804.
    View in: PubMed
    Score: 0.035
  13. Effects of patient-reported outcome assessment order. Clin Trials. 2022 06; 19(3):307-315.
    View in: PubMed
    Score: 0.033
  14. Financial Hardship in Survivorship Care Delivery. J Natl Cancer Inst Monogr. 2021 09 03; 2021(57):10-14.
    View in: PubMed
    Score: 0.032
  15. Associations between the gut microbiome and fatigue in cancer patients. Sci Rep. 2021 03 12; 11(1):5847.
    View in: PubMed
    Score: 0.031
  16. Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021 02; 18(1):104-114.
    View in: PubMed
    Score: 0.031
  17. Cancer-related Fatigue Reported in Online Discussion Groups. West J Nurs Res. 2021 05; 43(5):452-458.
    View in: PubMed
    Score: 0.030
  18. Factors affecting symptom presentation in an early-phase clinical trials clinic patient population. Invest New Drugs. 2020 08; 38(4):1166-1174.
    View in: PubMed
    Score: 0.029
  19. Validation study of the Arabic version of the Brief Fatigue Inventory (BFI-A). East Mediterr Health J. 2019 Nov 25; 25(11):784-790.
    View in: PubMed
    Score: 0.029
  20. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs. 2018 08; 36(4):638-646.
    View in: PubMed
    Score: 0.025
  21. What Do "None," "Mild," "Moderate," "Severe," and "Very Severe" Mean to Patients With Cancer? Content Validity of PRO-CTCAE? Response Scales. J Pain Symptom Manage. 2018 03; 55(3):e3-e6.
    View in: PubMed
    Score: 0.025
  22. Validity and Reliability of the Indonesian Version of the Brief Fatigue Inventory in Cancer Patients. J Pain Symptom Manage. 2016 11; 52(5):744-751.
    View in: PubMed
    Score: 0.023
  23. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials. Cancer. 2016 Nov 15; 122(21):3401-3409.
    View in: PubMed
    Score: 0.023
  24. Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Health Qual Life Outcomes. 2016 Feb 19; 14:24.
    View in: PubMed
    Score: 0.022
  25. Linguistic validation of the Spanish version of the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Support Care Cancer. 2016 07; 24(7):2843-51.
    View in: PubMed
    Score: 0.022
  26. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015 Nov; 1(8):1051-9.
    View in: PubMed
    Score: 0.022
  27. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014 Sep; 106(9).
    View in: PubMed
    Score: 0.020
  28. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors. Cancer. 2014 Feb 01; 120(3):425-32.
    View in: PubMed
    Score: 0.019
  29. A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer J. 2014 Jan-Feb; 20(1):8-14.
    View in: PubMed
    Score: 0.019
  30. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013 Dec 15; 119(24):4333-40.
    View in: PubMed
    Score: 0.019
  31. Authors' reply to Tendas et al. J Pain Symptom Manage. 2013 Apr; 45(4):e3-4.
    View in: PubMed
    Score: 0.018
  32. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manage. 2012 Aug; 44(2):168-80.
    View in: PubMed
    Score: 0.017
  33. Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data. Expert Rev Pharmacoecon Outcomes Res. 2011 Oct; 11(5):587-99.
    View in: PubMed
    Score: 0.016
  34. Studying cancer-related fatigue: report of the NCCN scientific research committee. J Natl Compr Canc Netw. 2010 Dec; 8(12):1331-9.
    View in: PubMed
    Score: 0.015
  35. Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancer. Cancer. 2011 Mar 01; 117(5):1070-9.
    View in: PubMed
    Score: 0.015
  36. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer. J Pain Symptom Manage. 2010 Jul; 40(1):75-86.
    View in: PubMed
    Score: 0.015
  37. Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms? J Pain Symptom Manage. 2010 Aug; 40(2):191-9.
    View in: PubMed
    Score: 0.015
  38. Impact of cultural and linguistic factors on symptom reporting by patients with cancer. J Natl Cancer Inst. 2010 May 19; 102(10):732-8.
    View in: PubMed
    Score: 0.015
  39. Development of a fatigue and functional impact scale in anemic cancer patients receiving chemotherapy. Cancer. 2008 Sep 15; 113(6):1480-8.
    View in: PubMed
    Score: 0.013
  40. Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past week. J Pain Symptom Manage. 2009 Feb; 37(2):168-74.
    View in: PubMed
    Score: 0.013
  41. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure. J Card Fail. 2008 Aug; 14(6):497-507.
    View in: PubMed
    Score: 0.013
  42. Psychometric properties of the brief fatigue inventory in Greek patients with advanced cancer. J Pain Symptom Manage. 2008 Oct; 36(4):367-73.
    View in: PubMed
    Score: 0.013
  43. Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage. 2008 Jun; 35(6):604-16.
    View in: PubMed
    Score: 0.013
  44. Health care providers' assessments of the quality of advanced-cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and Peru. J Pain Palliat Care Pharmacother. 2008; 22(1):7-20.
    View in: PubMed
    Score: 0.013
  45. Assessment of clinical relevant fatigue level in cancer. Support Care Cancer. 2007 Jul; 15(7):891-6.
    View in: PubMed
    Score: 0.012
  46. Symptoms in the lives of terminal cancer patients: which is the most important? Oncology. 2006; 71(1-2):69-76.
    View in: PubMed
    Score: 0.012
  47. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients. J Pain Symptom Manage. 2007 Feb; 33(2):180-8.
    View in: PubMed
    Score: 0.012
  48. Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage. 2006 Aug; 32(2):118-28.
    View in: PubMed
    Score: 0.011
  49. Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectiveness. Cancer. 2006 Jul 01; 107(1):207-14.
    View in: PubMed
    Score: 0.011
  50. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients. J Pain Symptom Manage. 2006 Jun; 31(6):542-52.
    View in: PubMed
    Score: 0.011
  51. Validation study of the Korean version of the M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2006 Apr; 31(4):345-52.
    View in: PubMed
    Score: 0.011
  52. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory. J Pain Symptom Manage. 2005 Nov; 30(5):443-53.
    View in: PubMed
    Score: 0.011
  53. The cancer pain experience of Israeli and American patients 65 years and older. J Pain Symptom Manage. 2005 Sep; 30(3):254-63.
    View in: PubMed
    Score: 0.011
  54. The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control. Support Care Cancer. 2005 Sep; 13(9):708-14.
    View in: PubMed
    Score: 0.010
  55. Validation study of the korean version of the brief fatigue inventory. J Pain Symptom Manage. 2005 Feb; 29(2):165-72.
    View in: PubMed
    Score: 0.010
  56. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients. Cancer. 2004 Oct 15; 101(8):1890-901.
    View in: PubMed
    Score: 0.010
  57. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004 Sep; 5(3):239-47.
    View in: PubMed
    Score: 0.010
  58. Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises: a retrospective case series. Clin J Pain. 2004 May-Jun; 20(3):195-7.
    View in: PubMed
    Score: 0.010
  59. Adequacy of cancer pain management in a Japanese Cancer Hospital. Jpn J Clin Oncol. 2004 Jan; 34(1):37-42.
    View in: PubMed
    Score: 0.009
  60. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventory. Oncology. 2004; 66(6):439-44.
    View in: PubMed
    Score: 0.009
  61. Japanese version of the MD Anderson Symptom Inventory: a validation study. J Pain Symptom Manage. 2003 Dec; 26(6):1093-104.
    View in: PubMed
    Score: 0.009
  62. Pediatric cancer pain management practices and attitudes in China. J Pain Symptom Manage. 2003 Aug; 26(2):748-59.
    View in: PubMed
    Score: 0.009
  63. Validation of the German version of the brief fatigue inventory. J Pain Symptom Manage. 2003 May; 25(5):449-58.
    View in: PubMed
    Score: 0.009
  64. Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adults. J Pain Symptom Manage. 2003 Apr; 25(4):307-18.
    View in: PubMed
    Score: 0.009
  65. The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage. 2002 Nov; 24(5):517-25.
    View in: PubMed
    Score: 0.009
  66. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002 Apr 15; 94(8):2295-304.
    View in: PubMed
    Score: 0.008
  67. Interpreting Patient-reported Outcome Scores for Clinical Research and Practice: Definition, Determination, and Application of Cutpoints. Med Care. 2019 05; 57 Suppl 5 Suppl 1:S8-S12.
    View in: PubMed
    Score: 0.007
  68. Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS). Support Care Cancer. 2019 Mar; 27(3):1021-1028.
    View in: PubMed
    Score: 0.007
  69. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995 May; 61(2):277-284.
    View in: PubMed
    Score: 0.005
  70. Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Qual Life Res. 2014 Feb; 23(1):257-69.
    View in: PubMed
    Score: 0.005
  71. Vertebral compression fracture treatment with vertebroplasty and kyphoplasty: experience in 407 patients with 1,156 fractures in a tertiary cancer center. Pain Med. 2011 Dec; 12(12):1750-7.
    View in: PubMed
    Score: 0.004
  72. Using confirmatory factor analysis to evaluate construct validity of the Brief Pain Inventory (BPI). J Pain Symptom Manage. 2011 Mar; 41(3):558-65.
    View in: PubMed
    Score: 0.004
  73. Validation of the Taiwanese version of the Brief Fatigue Inventory. J Pain Symptom Manage. 2006 Jul; 32(1):52-9.
    View in: PubMed
    Score: 0.003
  74. Pain education for underserved minority cancer patients: a randomized controlled trial. J Clin Oncol. 2004 Dec 15; 22(24):4918-25.
    View in: PubMed
    Score: 0.003
  75. Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C). J Pain Symptom Manage. 2004 Apr; 27(4):322-32.
    View in: PubMed
    Score: 0.002
  76. A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore). Pain. 1996 Apr; 65(1):87-92.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.